HEADER IMMUNE SYSTEM 06-JUN-14 4QKG TITLE MONOMERIC FORM OF HUMAN LLT1, A LIGAND FOR NKR-P1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: C-TYPE LECTIN DOMAIN FAMILY 2 MEMBER D; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR PART, UNP RESIDUES 72-191; COMPND 5 SYNONYM: LECTIN-LIKE NK CELL RECEPTOR, LECTIN-LIKE TRANSCRIPT 1, LLT- COMPND 6 1, OSTEOCLAST INHIBITORY LECTIN; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLAX, CLEC2B, CLEC2D, LLT1, OCIL; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293S GNTI-; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PTT28 KEYWDS C-TYPE LECTIN LIKE FOLD, LIGAND FOR HUMAN RECEPTOR NKR-P1, KEYWDS 2 GLYCOSYLATION; DEGLYCOSYLATED AFTER THE FIRST GLCNAC UNIT, ANCHORED KEYWDS 3 IN MEMBRANE ON CELL SURFACE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR T.SKALOVA,J.BLAHA,K.HARLOS,J.DUSKOVA,T.KOVAL,J.STRANSKY,J.HASEK, AUTHOR 2 O.VANEK,J.DOHNALEK REVDAT 6 08-NOV-23 4QKG 1 HETSYN REVDAT 5 29-JUL-20 4QKG 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 20-JUN-18 4QKG 1 JRNL REVDAT 3 13-JUN-18 4QKG 1 SOURCE REVDAT 2 27-JAN-16 4QKG 1 JRNL REVDAT 1 11-MAR-15 4QKG 0 JRNL AUTH T.SKALOVA,J.BLAHA,K.HARLOS,J.DUSKOVA,T.KOVAL,J.STRANSKY, JRNL AUTH 2 J.HASEK,O.VANEK,J.DOHNALEK JRNL TITL FOUR CRYSTAL STRUCTURES OF HUMAN LLT1, A LIGAND OF HUMAN JRNL TITL 2 NKR-P1, IN VARIED GLYCOSYLATION AND OLIGOMERIZATION STATES JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 71 578 2015 JRNL REFN ISSN 0907-4449 JRNL PMID 25760607 JRNL DOI 10.1107/S1399004714027928 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : CCP4 STEREOCHEMISTRY LIBRARY, VERSION 6.4.0 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 10029 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT (EXCEPT FOR THE REMARK 3 LAST CYCLE) REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 500 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 756 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 35 REMARK 3 BIN FREE R VALUE : 0.2900 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 883 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 19 REMARK 3 SOLVENT ATOMS : 42 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.37000 REMARK 3 B22 (A**2) : -0.37000 REMARK 3 B33 (A**2) : 1.19000 REMARK 3 B12 (A**2) : -0.37000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.149 REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.073 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.498 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 951 ; 0.016 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 828 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1295 ; 1.933 ; 1.925 REMARK 3 BOND ANGLES OTHERS (DEGREES): 1907 ; 0.942 ; 3.006 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 114 ; 7.717 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 49 ;27.796 ;23.878 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 157 ;15.138 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;12.996 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 128 ; 0.119 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1086 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 244 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 444 ; 3.612 ; 3.573 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 443 ; 3.610 ; 3.563 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 555 ; 5.096 ; 5.320 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 556 ; 5.092 ; 5.332 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 507 ; 4.645 ; 4.186 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 504 ; 4.622 ; 4.190 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 731 ; 7.006 ; 6.065 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 1091 ; 9.016 ;29.765 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1082 ; 8.921 ;29.677 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4QKG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000086167. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9796 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 OPTICS : KIRKPATRICK BAEZ MIRROR PAIR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10555 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.59900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4QKJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M AMMONIUM SULFATE, 0.1M SODIUM REMARK 280 CITRATE, PH 3.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.75800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.37900 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.37900 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 70.75800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 69 REMARK 465 THR A 70 REMARK 465 GLY A 71 REMARK 465 ASN A 147 REMARK 465 GLY A 148 REMARK 465 THR A 149 REMARK 465 GLU A 150 REMARK 465 TRP A 151 REMARK 465 THR A 152 REMARK 465 ARG A 153 REMARK 465 GLN A 154 REMARK 465 PHE A 155 REMARK 465 PRO A 156 REMARK 465 ILE A 157 REMARK 465 LEU A 158 REMARK 465 GLY A 159 REMARK 465 ALA A 160 REMARK 465 LYS A 194 REMARK 465 HIS A 195 REMARK 465 HIS A 196 REMARK 465 HIS A 197 REMARK 465 HIS A 198 REMARK 465 HIS A 199 REMARK 465 HIS A 200 REMARK 465 HIS A 201 REMARK 465 HIS A 202 REMARK 465 GLY A 203 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 130 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 130 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ARG A 180 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 83 82.41 27.23 REMARK 500 GLN A 83 -106.02 57.09 REMARK 500 ARG A 84 -4.93 69.11 REMARK 500 ASN A 167 -162.53 -105.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4QKH RELATED DB: PDB REMARK 900 RELATED ID: 4QKI RELATED DB: PDB REMARK 900 RELATED ID: 4QKJ RELATED DB: PDB DBREF 4QKG A 72 191 UNP Q9UHP7 CLC2D_HUMAN 72 191 SEQADV 4QKG ILE A 69 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG THR A 70 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG GLY A 71 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG CYS A 176 UNP Q9UHP7 HIS 176 ENGINEERED MUTATION SEQADV 4QKG GLY A 192 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG THR A 193 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG LYS A 194 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG HIS A 195 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG HIS A 196 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG HIS A 197 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG HIS A 198 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG HIS A 199 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG HIS A 200 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG HIS A 201 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG HIS A 202 UNP Q9UHP7 EXPRESSION TAG SEQADV 4QKG GLY A 203 UNP Q9UHP7 EXPRESSION TAG SEQRES 1 A 135 ILE THR GLY GLN ALA ALA CYS PRO GLU SER TRP ILE GLY SEQRES 2 A 135 PHE GLN ARG LYS CYS PHE TYR PHE SER ASP ASP THR LYS SEQRES 3 A 135 ASN TRP THR SER SER GLN ARG PHE CYS ASP SER GLN ASP SEQRES 4 A 135 ALA ASP LEU ALA GLN VAL GLU SER PHE GLN GLU LEU ASN SEQRES 5 A 135 PHE LEU LEU ARG TYR LYS GLY PRO SER ASP HIS TRP ILE SEQRES 6 A 135 GLY LEU SER ARG GLU GLN GLY GLN PRO TRP LYS TRP ILE SEQRES 7 A 135 ASN GLY THR GLU TRP THR ARG GLN PHE PRO ILE LEU GLY SEQRES 8 A 135 ALA GLY GLU CYS ALA TYR LEU ASN ASP LYS GLY ALA SER SEQRES 9 A 135 SER ALA ARG CYS TYR THR GLU ARG LYS TRP ILE CYS SER SEQRES 10 A 135 LYS SER ASP ILE HIS VAL GLY THR LYS HIS HIS HIS HIS SEQRES 11 A 135 HIS HIS HIS HIS GLY MODRES 4QKG ASN A 95 ASN GLYCOSYLATION SITE HET SO4 A 301 5 HET NAG A 302 14 HETNAM SO4 SULFATE ION HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 SO4 O4 S 2- FORMUL 3 NAG C8 H15 N O6 FORMUL 4 HOH *42(H2 O) HELIX 1 1 ASN A 95 SER A 105 1 11 HELIX 2 2 SER A 115 LYS A 126 1 12 SHEET 1 A 2 ALA A 73 ALA A 74 0 SHEET 2 A 2 ILE A 189 HIS A 190 -1 O ILE A 189 N ALA A 74 SHEET 1 B 5 ILE A 80 PHE A 82 0 SHEET 2 B 5 LYS A 85 PHE A 89 -1 O PHE A 87 N ILE A 80 SHEET 3 B 5 LYS A 181 SER A 187 -1 O LYS A 186 N CYS A 86 SHEET 4 B 5 HIS A 131 ARG A 137 1 N TRP A 132 O LYS A 181 SHEET 5 B 5 LYS A 144 TRP A 145 -1 O LYS A 144 N SER A 136 SHEET 1 C 5 ASP A 109 LEU A 110 0 SHEET 2 C 5 LYS A 181 SER A 187 -1 O SER A 185 N ASP A 109 SHEET 3 C 5 HIS A 131 ARG A 137 1 N TRP A 132 O LYS A 181 SHEET 4 C 5 GLU A 162 LEU A 166 -1 O LEU A 166 N HIS A 131 SHEET 5 C 5 ALA A 171 ARG A 175 -1 O SER A 172 N TYR A 165 SSBOND 1 CYS A 75 CYS A 86 1555 1555 2.06 SSBOND 2 CYS A 103 CYS A 184 1555 1555 2.09 SSBOND 3 CYS A 163 CYS A 176 1555 1555 2.05 LINK ND2 ASN A 95 C1 NAG A 302 1555 1555 1.45 CRYST1 47.298 47.298 106.137 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021143 0.012207 0.000000 0.00000 SCALE2 0.000000 0.024413 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009422 0.00000